10-K Filing

SOLENO THERAPEUTICS INC CIK: 1484565 FY 2017

Filing Information

Form Type	10-K
Accession Number	`0001193125-18-104048`
Period End Date	20171231
Filing Date	20180402
Fiscal Year	2017
Fiscal Period	FY
XBRL Instance	slno-20171231.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 56 Income Statement 46 Cash Flow Statement 87 Stockholders Equity 24 Comprehensive Income 1

Balance Sheet 56 line items

Line Item	Tag	Value	Unit	Period
Preferred stock par value (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock par value (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock shares authorized	`PreferredStockSharesAuthorized`	10.00M	shares	Point-in-time
Preferred stock shares authorized	`PreferredStockSharesAuthorized`	10.00M	shares	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$17.10M	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	100.00M	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$5.49M	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	100.00M	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$2.73M	USD	Point-in-time
Restricted cash	`RestrictedCashAndCashEquivalentsAtCarryingValue`	$35.00K	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	3.36M	shares	Point-in-time
Restricted cash	`RestrictedCashAndCashEquivalentsAtCarryingValue`	$35.00K	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$246.57K	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$342.93K	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	3.36M	shares	Point-in-time
Current assets held for sale	`AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent`	$793.73K	USD	Point-in-time
Total current assets	`AssetsCurrent`	$3.80M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$17.99M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$22.89K	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$42.02K	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$125.53K	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$125.53K	USD	Point-in-time
Intangible assets, net	`IntangibleAssetsNetExcludingGoodwill`	$20.41M	USD	Point-in-time
Long-term assets held for sale	`DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent`	$1.60M	USD	Point-in-time
Total assets	`Assets`	$5.56M	USD	Point-in-time
Total assets	`Assets`	$39.02M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$633.10K	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$410.51K	USD	Point-in-time
Accrued compensation and other current liabilities	`AccruedLiabilitiesAndOtherLiabilities`	$1.05M	USD	Point-in-time
Accrued compensation and other current liabilities	`AccruedLiabilitiesAndOtherLiabilities`	$973.05K	USD	Point-in-time
Current liabilities held for sale	`LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent`	$246.40K	USD	Point-in-time
Current liabilities held for sale	`LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent`	$126.61K	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$1.71M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$1.73M	USD	Point-in-time
Contingent liability for Essentialis purchase price	`BusinessCombinationContingentConsiderationLiabilityNoncurrent`	$5.08M	USD	Point-in-time
Other liabilities	`OtherLiabilitiesNoncurrent`	$61.74K	USD	Point-in-time
Other liabilities	`OtherLiabilitiesNoncurrent`	$13.16K	USD	Point-in-time
Long-term liabilities held for sale	`LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationNoncurrent`	$225.39K	USD	Point-in-time
Long-term liabilities held for sale	`LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationNoncurrent`	$81.00K	USD	Point-in-time
Total liabilities	`Liabilities`	$2.13M	USD	Point-in-time
Total liabilities	`Liabilities`	$12.49M	USD	Point-in-time
Commitments and contingencies (Note 7)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies (Note 7)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Common stock	`CommonStockValue`	$3.36K	USD	Point-in-time
Common stock	`CommonStockValue`	$19.24K	USD	Point-in-time
Additional paid-in-capital	`AdditionalPaidInCapitalCommonStock`	$101.74M	USD	Point-in-time
Additional paid-in-capital	`AdditionalPaidInCapitalCommonStock`	$140.49M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-113.98M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-98.31M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$3.44M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$3.22M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$26.53M	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$5.56M	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$39.02M	USD	Point-in-time

Income Statement 46 line items

Line Item	Tag	Value	Unit	Period
Research and development	`ResearchAndDevelopmentExpense`	$3.07M	USD	Annual
Research and development	`ResearchAndDevelopmentExpense`	$2.25M	USD	Annual
Sales and marketing	`SellingAndMarketingExpense`	-	USD	Annual
Sales and marketing	`SellingAndMarketingExpense`	$25.73K	USD	Annual
General and administrative	`GeneralAndAdministrativeExpense`	$6.58M	USD	Annual
General and administrative	`GeneralAndAdministrativeExpense`	$6.08M	USD	Annual
Change in fair value of contingent consideration	`BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1`	$2.49M	USD	Annual
Change in fair value of contingent consideration	`BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1`	-	USD	Annual
Total operating expenses	`OperatingExpenses`	$12.17M	USD	Annual
Total operating expenses	`OperatingExpenses`	$8.32M	USD	Annual
Operating loss	`OperatingIncomeLoss`	$-8.32M	USD	Annual
Operating loss	`OperatingIncomeLoss`	$-12.17M	USD	Annual
Cease-use income (expense)	`GainLossOnContractTermination`	$-93.75K	USD	Annual
Cease-use income (expense)	`GainLossOnContractTermination`	$4.17K	USD	Annual
Change in fair value of warrants liabilities	`FairValueAdjustmentOfWarrants`	$967.05K	USD	Annual
Change in fair value of warrants liabilities	`FairValueAdjustmentOfWarrants`	$-1.67M	USD	Annual
Other income (expense)	`OtherNonrecurringExpense`	$-13.13K	USD	Annual
Other income (expense)	`OtherNonrecurringExpense`	$590.11K	USD	Annual
Total other income (expense)	`OtherNonoperatingIncomeExpense`	$-1.55M	USD	Annual
Total other income (expense)	`OtherNonoperatingIncomeExpense`	$1.59M	USD	Annual
Loss from continuing operations before provision for income tax benefit	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-13.72M	USD	Annual
Loss from continuing operations before provision for income tax benefit	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-6.74M	USD	Annual
Provision for income tax benefit from continuing operations	`IncomeTaxExpenseBenefit`	-	USD	Annual
Provision for income tax benefit from continuing operations	`IncomeTaxExpenseBenefit`	$-1.65M	USD	Annual
Loss from continuing operations	`IncomeLossFromContinuingOperations`	$-12.07M	USD	Annual
Loss from continuing operations	`IncomeLossFromContinuingOperations`	$-6.74M	USD	Annual
Operating loss	`DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodNetOfTax`	$-5.33M	USD	Annual
Operating loss	`DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodNetOfTax`	$-3.41M	USD	Annual
Loss on sale of assets, net of tax effect	`DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax`	$-185.98K	USD	Annual
Loss on sale of assets, net of tax effect	`DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax`	-	USD	Annual
Loss from discontinued operations	`IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity`	$-5.33M	USD	Annual
Loss from discontinued operations	`IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity`	$-3.59M	USD	Annual
Net loss	`NetIncomeLoss`	$-15.67M	USD	Annual
Net loss	`NetIncomeLoss`	$-12.07M	USD	Annual
Loss per common share from continuing operations, basic and diluted (Note 14) (in usd per share)	`IncomeLossFromContinuingOperationsPerBasicAndDilutedShare`	-	USD	Annual
Loss per common share from continuing operations, basic and diluted (Note 14) (in usd per share)	`IncomeLossFromContinuingOperationsPerBasicAndDilutedShare`	-	USD	Annual
Loss on extinguishment of convertible preferred stock	`PreferredStockDividendsAndOtherAdjustments`	$3.65M	USD	Annual
Loss on extinguishment of convertible preferred stock	`PreferredStockDividendsAndOtherAdjustments`	-	USD	Annual
Net loss applicable to common stockholders	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-15.72M	USD	Annual
Net loss applicable to common stockholders	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-15.67M	USD	Annual
Loss per common share from discontinued operations, basic and diluted	`DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicAndDilutedShare`	$-0.40	USD	Annual
Loss per common share from discontinued operations, basic and diluted	`DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicAndDilutedShare`	$-1.72	USD	Annual
Net loss per common share, basic and diluted	`EarningsPerShareBasicAndDiluted`	$-5.07	USD	Annual
Net loss per common share, basic and diluted	`EarningsPerShareBasicAndDiluted`	$-1.75	USD	Annual
Weighted-average common shares outstanding used to calculate basic and diluted net loss per common share	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	3.10M	shares	Annual
Weighted-average common shares outstanding used to calculate basic and diluted net loss per common share	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	8.98M	shares	Annual

Cash Flow Statement 87 line items

Line Item	Tag	Value	Unit	Period
Net loss	`NetIncomeLoss`	$-15.67M	USD	Annual
Net loss	`NetIncomeLoss`	$-12.07M	USD	Annual
Loss from discontinued operations	`IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity`	$-5.33M	USD	Annual
Loss from discontinued operations	`IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity`	$-3.59M	USD	Annual
Loss from continuing operations	`IncomeLossFromContinuingOperations`	$-12.07M	USD	Annual
Loss from continuing operations	`IncomeLossFromContinuingOperations`	$-6.74M	USD	Annual
Depreciation and amortization	`DepreciationAndAmortization`	$18.67K	USD	Annual
Depreciation and amortization	`DepreciationAndAmortization`	$1.61M	USD	Annual
Stock-based compensation expense	`ShareBasedCompensation`	$880.03K	USD	Annual
Stock-based compensation expense	`ShareBasedCompensation`	$739.23K	USD	Annual
Income tax benefit	`IncreaseDecreaseInIncomeTaxes`	-	USD	Annual
Income tax benefit	`IncreaseDecreaseInIncomeTaxes`	$-1.65M	USD	Annual
Board fees paid with common stock	`OtherNoncashExpense`	$24.40K	USD	Annual
Board fees paid with common stock	`OtherNoncashExpense`	$277.79K	USD	Annual
Change in fair value of stock warrants	`FairValueAdjustmentOfWarrants`	$967.05K	USD	Annual
Change in fair value of stock warrants	`FairValueAdjustmentOfWarrants`	$-1.67M	USD	Annual
Change in fair value of contingent consideration	`BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1`	$2.49M	USD	Annual
Change in fair value of contingent consideration	`BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1`	-	USD	Annual
Loss on disposition of equipment	`GainLossOnSaleOfPropertyPlantEquipment`	$-768.00	USD	Annual
Loss on disposition of equipment	`GainLossOnSaleOfPropertyPlantEquipment`	-	USD	Annual
Inducement charge for Series C warrants	`InducedConversionOfConvertibleDebtExpense`	-	USD	Annual
Noncash expense of issuing shares to Aspire Capital	`NoncashExpenseOnSharesIssued`	-	USD	Annual
Noncash expense of issuing shares to Aspire Capital	`NoncashExpenseOnSharesIssued`	$602.08K	USD	Annual
Prepaid expenses and other assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$-87.55K	USD	Annual
Prepaid expenses and other assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$-96.36K	USD	Annual
Other long-term assets	`IncreaseDecreaseInOtherNoncurrentAssets`	$-49.19K	USD	Annual
Other long-term assets	`IncreaseDecreaseInOtherNoncurrentAssets`	-	USD	Annual
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$190.63K	USD	Annual
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$-76.83K	USD	Annual
Accrued compensation and other current liabilities	`IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities`	$-78.30K	USD	Annual
Accrued compensation and other current liabilities	`IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities`	$534.49K	USD	Annual
Other long-term liabilities	`IncreaseDecreaseInOtherNoncurrentLiabilities`	$40.04K	USD	Annual
Other long-term liabilities	`IncreaseDecreaseInOtherNoncurrentLiabilities`	$-40.04K	USD	Annual
Net cash used in continuing operating activities	`NetCashProvidedByUsedInOperatingActivitiesContinuingOperations`	$-6.92M	USD	Annual
Net cash used in continuing operating activities	`NetCashProvidedByUsedInOperatingActivitiesContinuingOperations`	$-7.26M	USD	Annual
Net cash used in discontinued operations	`CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations`	$-6.24M	USD	Annual
Net cash used in discontinued operations	`CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations`	$-3.03M	USD	Annual
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-9.95M	USD	Annual
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-13.50M	USD	Annual
Costs of Essentialis acquisition	`PaymentsToAcquireBusinessesNetOfCashAcquired`	-	USD	Annual
Costs of Essentialis acquisition	`PaymentsToAcquireBusinessesNetOfCashAcquired`	$572.59K	USD	Annual
Security deposit on sublease	`ProceedsFromSecurityDepositOnSublease`	-	USD	Annual
Security deposit on sublease	`ProceedsFromSecurityDepositOnSublease`	$13.16K	USD	Annual
Purchase of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$2.57K	USD	Annual
Purchase of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$14.79K	USD	Annual
Net cash used in continuing investing activities	`NetCashProvidedByUsedInInvestingActivitiesContinuingOperations`	$-14.79K	USD	Annual
Net cash used in continuing investing activities	`NetCashProvidedByUsedInInvestingActivitiesContinuingOperations`	$-562.00K	USD	Annual
Net cash provided by (used in) discontinued investing activities	`CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations`	$940.78K	USD	Annual
Net cash provided by (used in) discontinued investing activities	`CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations`	$-23.89K	USD	Annual
Net cash provided by (used in) investing activities	`NetCashProvidedByUsedInInvestingActivities`	$378.78K	USD	Annual
Net cash provided by (used in) investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-38.68K	USD	Annual
Proceeds from issuance of common stock	`ProceedsFromIssuanceOfCommonStock`	-	USD	Annual
Proceeds from issuance of common stock	`ProceedsFromIssuanceOfCommonStock`	$10.00M	USD	Annual
Proceeds from sale of common stock and common stock warrants	`ProceedsFromSaleOfCommonStockAndCommonStockWarrants`	-	USD	Annual
Proceeds from sale of common stock and common stock warrants	`ProceedsFromSaleOfCommonStockAndCommonStockWarrants`	$15.01M	USD	Annual
Cash paid for the cost issuance of common stock and common stock warrants	`CashPaidForTheCostIssuanceOfCommonStockAndCommonStockWarrants`	-	USD	Annual
Cash paid for the cost issuance of common stock and common stock warrants	`CashPaidForTheCostIssuanceOfCommonStockAndCommonStockWarrants`	$1.06M	USD	Annual
Proceeds from exercise of common stock options	`ProceedsFromStockOptionsExercised`	$70.10K	USD	Annual
Proceeds from exercise of common stock options	`ProceedsFromStockOptionsExercised`	-	USD	Annual
Net cash provided by continuing financing activities	`NetCashProvidedByUsedInFinancingActivitiesContinuingOperations`	$23.94M	USD	Annual
Net cash provided by continuing financing activities	`NetCashProvidedByUsedInFinancingActivitiesContinuingOperations`	$10.77M	USD	Annual
Net cash provided by discontinued financing activities	`CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations`	-	USD	Annual
Net cash provided by discontinued financing activities	`CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations`	-	USD	Annual
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$23.94M	USD	Annual
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$10.77M	USD	Annual
Net decrease in cash and cash equivalents from discontinued operations	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$-2.77M	USD	Annual
Net decrease in cash and cash equivalents from discontinued operations	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$14.37M	USD	Annual
Cash and cash equivalents, beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$17.10M	USD	Point-in-time
Cash and cash equivalents, beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$5.49M	USD	Point-in-time
Cash and cash equivalents, beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$2.73M	USD	Point-in-time
Cash and cash equivalents, end of period	`CashAndCashEquivalentsAtCarryingValue`	$17.10M	USD	Point-in-time
Cash and cash equivalents, end of period	`CashAndCashEquivalentsAtCarryingValue`	$5.49M	USD	Point-in-time
Cash and cash equivalents, end of period	`CashAndCashEquivalentsAtCarryingValue`	$2.73M	USD	Point-in-time
Cash paid for income taxes	`IncomeTaxesPaid`	-	USD	Annual
Cash paid for income taxes	`IncomeTaxesPaid`	$800.00	USD	Annual
Issuance of common stock for Essentialis acquisition	`StockIssued1`	$17.25M	USD	Annual
Issuance of common stock for Essentialis acquisition	`StockIssued1`	-	USD	Annual
Warrants issued in connection with sale of common stock	`WarrantsIssuedInConnectionWithSaleOfCommonStock`	-	USD	Annual
Warrants issued in connection with sale of common stock	`WarrantsIssuedInConnectionWithSaleOfCommonStock`	$4.19M	USD	Annual
Contingent cash consideration of Essentialis acquisition	`NoncashOrPartNoncashAcquisitionContingentConsideration`	-	USD	Annual
Contingent cash consideration of Essentialis acquisition	`NoncashOrPartNoncashAcquisitionContingentConsideration`	$2.59M	USD	Annual
Costs of issuing common stock and common stock warrants recorded in accounts payable	`CostsOfIssuingCommonStockAndCommonStockWarrantsRecordedInAccountsPayable`	$117.16K	USD	Annual
Costs of issuing common stock and common stock warrants recorded in accounts payable	`CostsOfIssuingCommonStockAndCommonStockWarrantsRecordedInAccountsPayable`	-	USD	Annual
Preferred convertible stock transaction costs included in Accounts Payable	`TransactionCostsIncludedinAccruedLiabilities`	$52.29K	USD	Annual
Preferred convertible stock transaction costs included in Accounts Payable	`TransactionCostsIncludedinAccruedLiabilities`	-	USD	Annual
Fixed asset purchases included in accounts payable	`FairValueOfAssetsAcquired`	-	USD	Annual
Fixed asset purchases included in accounts payable	`FairValueOfAssetsAcquired`	$11.20K	USD	Annual

Stockholders Equity 24 line items

Line Item	Tag	Value	Unit	Period
Redemption of Series A Convertible Preferred	`StockRepurchasedDuringPeriodValue`	$7.78M	USD	Annual
Balances at beginning	`StockholdersEquity`	$3.44M	USD	Point-in-time
Balances at beginning	`StockholdersEquity`	$3.22M	USD	Point-in-time
Balances at beginning	`StockholdersEquity`	$26.53M	USD	Point-in-time
Stock-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$1.00M	USD	Annual
Stock-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$871.27K	USD	Annual
Less transaction costs	`AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts`	$1.17M	USD	Annual
Issuance of common stock for stock option exercises	`StockIssuedDuringPeriodValueStockOptionsExercised`	$70.10K	USD	Annual
Redemption of Series A Convertible Preferred	`StockRepurchasedDuringPeriodValue`	$7.78M	USD	Annual
Issuance of common stock to board members in lieu of cash payments for quarterly board fees	`StockIssuedDuringPeriodValueIssuedForServices`	$277.79K	USD	Annual
Issuance of common stock to board members in lieu of cash payments for quarterly board fees	`StockIssuedDuringPeriodValueIssuedForServices`	$24.41K	USD	Annual
Net loss	`NetIncomeLoss`	$-15.67M	USD	Annual
Net loss	`NetIncomeLoss`	$-12.07M	USD	Annual
Balances at end	`StockholdersEquity`	$3.44M	USD	Point-in-time
Balances at end	`StockholdersEquity`	$3.22M	USD	Point-in-time
Balances at end	`StockholdersEquity`	$26.53M	USD	Point-in-time
Issuance of shares to Aspire Capital in lieu of commitment fees	`IssuanceOfStockAndWarrantsForServicesOrClaims`	$602.08K	USD	Annual
Rounding adjustment resulting from 1 for 5 reverse split	`StockIssuedDuringPeriodValueReverseStockSplits`	-	USD	Annual
Fair value at transaction date of warrants to purchase common stock under the 2017 PIPE (Shares)	`FairValueAtTransactionDateOfWarrantsToPurchaseCommonStockShares`	0.00	shares	Annual
Net loss	`NetIncomeLoss`	$-15.67M	USD	Annual
Net loss	`NetIncomeLoss`	$-12.07M	USD	Annual
Balances at end	`StockholdersEquity`	$3.44M	USD	Point-in-time
Balances at end	`StockholdersEquity`	$3.22M	USD	Point-in-time
Balances at end	`StockholdersEquity`	$26.53M	USD	Point-in-time

Comprehensive Income 1 line items

Line Item	Tag	Value	Unit	Period
Less transaction costs	`AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts`	$1.17M	USD	Annual

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.